Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of Deep Learning and Traditional Machine Learning Models for Predicting Mild Cognitive Impairment Using Plasma Proteomic Biomarkers

8 Mar 2025

Abstract excerpt

Mild cognitive impairment (MCI) is a clinical condition characterized by a decline in cognitive ability and progression of cognitive impairment. It is often considered a transitional stage between normal aging and Alzheimer’s disease (AD). This study aimed to compare deep learning (DL) and traditional machine learning (ML) methods in predicting MCI using plasma proteomic biomarkers. A total of 239 adults were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Bioinformatics and Genomic Networks
Share to Dementia and Cognitive Impairment Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40141072
DOI: 10.3390/ijms26062428

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of Deep Learning and Traditional Machine Learning Models for Predicting Mild Cognitive Impairment Using Plasma Proteomic BiomarkersPMID 40141072Read ↗

Risk Score Stratification of Alzheimer’s Disease and Mild Cognitive Impairment using Deep LearningSemantic proximity Read ↗

Dementia etiology classification using NULISA plasma biomarkers and machine learningSemantic proximity Read ↗

Machine learning models for dementia risk prediction: Evidence from the Sydney Memory and Ageing StudySemantic proximity Read ↗

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in DementiaSemantic proximity Read ↗

A machine learning framework for classifying dementia risk in mild cognitive impairment: evidence from a Korean genome-wide association study cohort.Semantic proximity Read ↗

Classification and deep-learning–based prediction of Alzheimer disease subtypes by using genomic dataSemantic proximity Read ↗

Proteome profiling of cerebrospinal fluid using machine learning shows a unique protein signature associated with APOE4 genotypeSemantic proximity Read ↗

Proteome profiling of cerebrospinal fluid using machine learning shows a unique protein signature associated with APOE4 genotype.Semantic proximity Read ↗

Standardized Comparison of Clinical, Cognitive, Genetic, Neuroimaging, and Fluid Biomarkers for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity Read ↗

Blood biomarker-based classification study for neurodegenerative diseasesSemantic proximity Read ↗

Novel Plasma Protein Biomarkers: A Time-Dependent predictive model for Alzheimer's DiseaseSemantic proximity Read ↗

Identifying Proteomic Prognostic Markers for Alzheimer’s Disease with Survival Machine Learning: the Framingham Heart StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.